IOL Chemicals & Pharmaceuticals Ltd reports Q2 FY27 revenue of ₹795 crore, up 40.1% year on year
- EBITDA was ₹114.9 crore, with a 14.4% margin versus 11.1% in Q2 FY26.
- PAT rose 116.8% year on year and 0.8% sequentially to ₹65 crore; PAT margin was 8.1%.